These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6167446)

  • 1. Estimation of differential in vitro sensitivity of non-Hodgkin lymphomas to anticancer drugs.
    Sanfilippo O; Daidone MG; Costa A; Canetta R; Silvestrini R
    Eur J Cancer (1965); 1981 Feb; 17(2):217-26. PubMed ID: 6167446
    [No Abstract]   [Full Text] [Related]  

  • 2. [ABP therapy in advanced non-Hodgkin's lymphoma resistant to VCP therapy].
    Kuraishi Y; Ozeki H; Takasaki N; Mashizu N; Nagamine D; Usui N; Yamazaki H; Nakamura T; Aiba K; Yokoyama K
    Rinsho Ketsueki; 1984 Sep; 25(9):1427-32. PubMed ID: 6084069
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination chemotherapy of advanced, diffuse, non-Hodgkin's lymphoma: results with cyclo-phosphamide, adriamycin, vincristine, prednisone, and bleomycin (CHOP-Bleo).
    Case DC
    J Maine Med Assoc; 1979 Sep; 70(9):348-50, 352, 368. PubMed ID: 92513
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy of the non-Hodgkin's lymphomas.
    Pasmantier MW; Coleman M; Silver RT
    Med Clin North Am; 1976 Sep; 60(5):1043-52. PubMed ID: 59842
    [No Abstract]   [Full Text] [Related]  

  • 5. A quantitative test for chemosensitivity of short-term cultures of human lymphomas.
    Costa A; Piazza R; Sanfilippo O; Silvestrini R
    Tumori; 1977; 63(3):237-47. PubMed ID: 898291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New agents and combination chemotherapy of non-Hodgkin's lymphoma.
    Skarin AT; Frei E; Moloney WC; Gutterman JU
    Br J Cancer Suppl; 1975 Mar; 2():497-504. PubMed ID: 52368
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of non-Hodgkin lymphomas of a high degree of malignancy].
    Höche D; Herold M; Wutke K; Rüdiger KD; Anger G; Kästner R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):671-7. PubMed ID: 6172332
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of lymphoma in the aged].
    Gómez H; Colomer R
    Med Clin (Barc); 1998 May; 110(15):574-5. PubMed ID: 9650201
    [No Abstract]   [Full Text] [Related]  

  • 9. [Management of lymphoma with respect to pathologic classification: updates and controversies].
    Zhu J; Song YQ
    Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):724-7. PubMed ID: 20079009
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of malignant lymphomas with shock doses of peptichemio].
    Battelli T; Bonsignori M; Manocchi P
    Minerva Med; 1975 Jun; 66(43):2087-93. PubMed ID: 49865
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term results of patients with advanced diffuse, non-Hodgkin's lymphoma treated with cyclophosphamide, doxorubicin, vincristine, prednisone and bleomycin (CHOP-Bleo).
    Case DC
    Oncology; 1983; 40(3):186-91. PubMed ID: 6189041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of non-Hodgkin lymphomas].
    Izzi T; Porcellini A; Delfini C; Lucarelli G
    Minerva Med; 1982 Apr; 73(15):949-53. PubMed ID: 7078792
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study.
    Longo DL; Duffey PL; Gribben JG; Jaffe ES; Curti BD; Gause BL; Janik JE; Braman VM; Esseltine D; Wilson WH; Kaufman D; Wittes RE; Nadler LM; Urba WJ
    Cancer J; 2000; 6(3):146-50. PubMed ID: 10882329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intermediate evaluation of a prospective study of the therapy of malignant non-Hodgkin lymphomas].
    Jandl H; Franke A; Kammerer R; Spormann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):678-84. PubMed ID: 6172333
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of non-Hodgkin lymphomas].
    Fleischer J
    Z Gesamte Inn Med; 1979 Jul; 34(13):173-6. PubMed ID: 94197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten years' experience with four cycles of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, procarbazine (BEACOPP)-escalated followed by four cycles of baseline-dose BEACOPP in patients with advanced stage Hodgkin lymphoma: a single-center, retrospective study.
    Belada D; Štěpánková P; Sýkorová A; Žák P; Smolej L
    Leuk Lymphoma; 2015 Jul; 56(7):2013-8. PubMed ID: 25330440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A kinetically designed chemotherapeutic regimen for advanced refractory lymphoma patients.
    Rossof AH; Kerr RO; Braine HG; Coltman CA
    Med Pediatr Oncol; 1978; 4(2):133-9. PubMed ID: 78437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug therapy of malignant lymphoma].
    Ogawa M; Inagaki J
    Rinsho Hoshasen; 1985 Oct; 30(11):1317-32. PubMed ID: 2418229
    [No Abstract]   [Full Text] [Related]  

  • 19. [Criteria for choice of therapeutic procedures in lymphomas].
    Vettore L; Pizzolo G
    Minerva Med; 1975 Apr; 66(31):1456-62. PubMed ID: 48217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and therapeutic aspects of non-Hodgkin lymphoma with primary digestive localization].
    Stoica I; Gociu M; Moţoiu I; Coliţă D; Berceanu S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(1):11-8. PubMed ID: 6203154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.